share_log

京投交通科技(01522)发盈喜 预计中期股东应占溢利约900万港元至1000万港元

Bii Trans Tech (01522) announced a profit alert, with an expected interim net profit attributable to shareholders of approximately 9 million HKD to 10 million HKD.

Zhitong Finance ·  Aug 19 06:58

Bii Trans Tech (01522) announced that it is expected to record...

According to the announcement released by shareholder Bii Trans Tech (01522), the group is expected to record a revenue of approximately HKD 0.469 billion for the six months ending on June 30, 2024, which is not significantly different from the revenue of about HKD 0.473 billion for the same period of last year. It is also expected that the attributable net profit to equity shareholders of the company will be approximately HKD 9 million to HKD 10 million, while it was about HKD 5.1 million for the same period of last year. The expected increase in net profit attributable to equity shareholders of the company is mainly due to the improvement of cost control measures during the period. At the same time, the high growth in net profit during this period is due to the relatively low base of the same period of last year. Considering the seasonal patterns of revenue recognition in the company’s previous years, it is expected that the growth of net profit for this period will not have a significant impact on the full-year performance.

The expected increase in net profit attributable to equity shareholders of the company is mainly due to the improvement of cost control measures during the period. At the same time, the high growth in net profit during this period is due to the relatively low base of the same period of last year. Considering the seasonal patterns of revenue recognition in the company’s previous years, it is expected that the growth of net profit for this period will not have a significant impact on the full-year performance.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment